Vangl1tm1e(KOMP)Wtsi
Targeted Allele Detail
|
Symbol: |
Vangl1tm1e(KOMP)Wtsi |
Name: |
VANGL planar cell polarity 1; targeted mutation 1e, Wellcome Trust Sanger Institute |
MGI ID: |
MGI:4365105 |
Gene: |
Vangl1 Location: Chr3:102060899-102112009 bp, - strand Genetic Position: Chr3, 44.3 cM
|
Alliance: |
Vangl1tm1e(KOMP)Wtsi page
|
IMPC: |
Vangl1 gene page |
|
Mutant Cell Lines: |
EPD0164_3_D08, EPD0164_3_E06, EPD0164_3_G07, EPD0164_3_H07 |
Germline Transmission: |
Earliest citation of germline transmission:
J:204812
|
Parent Cell Line: |
JM8.N4 (ES Cell)
|
Strain of Origin: |
C57BL/6N
|
Project Collection: |
KOMP-CSD
|
|
Allele Type: |
|
Targeted (Null/knockout, Reporter) |
Mutation: |
|
Insertion
Vector: L1L2_Bact_P
|
|
|
Mutation details: The L1L2_Bact_P cassette was inserted at position 102092345 of Chromosome 3 upstream of the critical exon(s) (Build GRCm39). The cassette is composed of an FRT site followed by lacZ sequence and a loxP site. This first loxP site is followed by a neomycin resistance gene under the control of the human beta-actin promoter, SV40 polyA, a second FRT site and a second loxP site. Insertion of this cassette creates a reporter knockout mouse. Cre expression will remove the neomycin selection cassette. Further information on targeting strategies used for this and other IKMC alleles can be found at http://www.informatics.jax.org/mgihome/nomen/IKMC_schematics.shtml
(J:148605, J:173534)
|
|
|
View phenotypes and curated references for all genotypes (concatenated display).
|
|
|
Original: |
J:148605 Wellcome Trust Sanger Institute, Alleles produced for the KOMP project by the Wellcome Trust Sanger Institute. MGI Direct Data Submission. 2009; |
All: |
8 reference(s) |
|